Course Description
The menopause transition is a critical period marked by hormonal shifts that can contribute to the onset or worsening of anxiety and depression. This session unpacks the science behind these symptoms, outlines who’s most at risk, and offers evidence-based treatment options that go beyond hormones. With their unique expertise, psychiatric pharmacists can play a vital role in closing the care gap and empowering midlife patients with meaningful support.
Learning Objectives
- Describe the etiology of hormonal changes related to mental health that occur during menopause transition.
- Name risk factors for developing new onset or worsening anxiety and/or depression during menopause transition.
- Identify evidence-based treatment recommendations for women experiencing vasomotor and/or mood symptoms.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this course.
Faculty
View biographical information
Lisa Miller, MA, PharmD, BSCP
Associate Dean, Clinical Professor
University of Florida College of Pharmacy
Orlando, FL
Dr. Lisa Miller is the Associate Dean at the University of Florida College of Pharmacy’s Orlando Campus, where she is actively engaged in teaching, research, and administration. She is also the owner of Women’s Precision Health, LLC, a menopause consult service for midlife women and healthcare providers. With a background in both pharmacy and clinical mental health counseling, she brings a unique, interdisciplinary perspective to pharmacy education and patient care.
Dr. Lisa Miller earned her B.S. in Pharmacy from The Ohio State University, her Pharm.D. from University of Kentucky, and an M.A. in Clinical Mental Health Counseling from Liberty University. She completed a postdoctoral clinical pharmacy residency at Wake Forest Baptist Medical Center and is a Menopause Society Certified Menopause Practitioner.
Dr. Lisa Miller is committed to advancing the role of pharmacists in patient-centered care and medication management, particularly in areas impacting midlife and women’s health. Through her work, she aims to bridge the gap between clinical pharmacy, mental health, and pharmacy education by equipping students with the knowledge and skills needed to improve patient outcomes.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: 4/21/2026-4/21/2029
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-26-025-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
View Faculty and Program Planning Committee Disclosures of Interest
Faculty: Lisa Miller, PharmD, MSCP, LCMHCA, NCC has nothing to disclose
Planning Committee: Members and disclosures listed here
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. The faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Copyright Statement, Terms of Use, and Policies
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Privacy Policy. AAPP's Terms of Use and other policies on education programs, resources, toolkits, and other web based content/offerings are available here.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.